[
    {
        "title": "Tak PPea. Sustained inhibition of progressive joint damage with rituximab plus methotrexate in early active rheumatoid arthritis: 2-year results from the randomised controlled trial IMAGE. Ann Rheum Dis BMJ. 2011;71(3):351-7.",
        "paper_uid": "2f031aec",
        "reference": "Tak PPea. Sustained inhibition of progressive joint damage with rituximab plus methotrexate in early active rheumatoid arthritis: 2-year results from the randomised controlled trial IMAGE. Ann Rheum Dis BMJ. 2011;71(3):351-7.",
        "save_folder_path": null,
        "study_design": "Randomized Controlled Trial"
    },
    {
        "title": "RIGBY WF, G.; GREENWALD, M.; ZAZUETA-MONTIEL, B.; et. al. Effect of Rituximab on Physical Function and Quality of Life in Patients With Rheumatoid Arthritis Previously Untreated With Methotrexate. American College of Rheumatology. 2011;63(5):711-20.",
        "paper_uid": "9d737999",
        "reference": "RIGBY WF, G.; GREENWALD, M.; ZAZUETA-MONTIEL, B.; et. al. Effect of Rituximab on Physical Function and Quality of Life in Patients With Rheumatoid Arthritis Previously Untreated With Methotrexate. American College of Rheumatology. 2011;63(5):711-20.",
        "save_folder_path": null,
        "study_design": "Randomized Controlled Trial"
    },
    {
        "title": "Lopez-Olivo MAT, J.H; Martinez-Lopez, J.A.; Pollono, E.N.; Cueto, J.P.; Gonzales-Crespo, M.R.; Fulton, S.; Suarez-Almazor, M.E. Risk of malignancies in patients with rheumatoid arthritis treated with biologic therapy: a meta-analysis. JAMA. 2012;308(9):898.",
        "paper_uid": "45b0286b",
        "reference": "Lopez-Olivo MAT, J.H; Martinez-Lopez, J.A.; Pollono, E.N.; Cueto, J.P.; Gonzales-Crespo, M.R.; Fulton, S.; Suarez-Almazor, M.E. Risk of malignancies in patients with rheumatoid arthritis treated with biologic therapy: a meta-analysis. JAMA. 2012;308(9):898.",
        "save_folder_path": null,
        "study_design": "SYSTEMATIC_REVIEW"
    }
]